Skip to main content
Erschienen in: Abdominal Radiology 5/2018

28.08.2017

Imaging appearance of fibrosing diseases of the retroperitoneum: can a definitive diagnosis be made?

verfasst von: Richard H. Cohan, Kimberley L. Shampain, Isaac R. Francis, Matthew S. Davenport, J. Stuart Wolf, Wendy Marder, Richard D. Swartz

Erschienen in: Abdominal Radiology | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess the frequency with which previously reported characteristic findings of retroperitoneal fibrosis (RPF) (a circumferential or almost circumferential peri-aortic mass centered at L4, which does not displace the abdominal aorta or proximal common iliac arteries) are present in patients with RPF, in patients with other fibrosing diseases, and in cancer patients referred to a subspecialty clinic with a suspected diagnosis of RPF, in order to determine whether diagnostic percutaneous biopsy can be avoided in some patients.

Methods

This HIPAA-compliant Institutional Review Board-approved retrospective study assessed clinical and CT and MR imaging abnormalities on imaging studies in 92 patients referred to a subspecialty clinic with suspected RPF over a 14-year period. Two reviewers, in consensus, determined the frequency of different CT and MRI findings in three groups of patients (Group 1: those with an eventual diagnosis of RPF, Group 2: those with a fibrosing disease associated with vascular or urologic abnormalities, and Group 3: those with cancer). Assessed imaging features included the presence of retroperitoneal masses, whether masses were single or multiple, whether such masses were circumferential or nearly circumferential, whether they displaced the aorta away from the spine (with the degree of such displacement measured), and whether there were abnormalities outside of the peri-aortic region of the retroperitoneum. The frequency with which findings previously reported as characteristic of RPF were present was determined for each of the three groups. Imaging results were correlated with the final diagnoses.

Results

Of 68 subjects eventually diagnosed with retroperitoneal fibrosis (RPF) (Group 1), 47 had peri-aortic retroperitoneal masses, 18 of which displaced the aorta anteriorly away from the spine. Of 12 subjects with fibrosing abnormalities related to vascular or urologic disease (Group 2), six had retroperitoneal masses, none of which displaced the aorta away from the spine. Of 12 subjects with malignancies (Group 3), six had peri-aortic retroperitoneal masses only two of whom had aortic displacement. Only 34 of 68 Group 1 subjects had peri-aortic masses characteristic of RPF, compared with six Group 2 subjects and one Group 3 subject. Subjects with characteristic retroperitoneal masses were significantly more likely to have benign disease than cancer (p = 0.009).

Conclusion

Many patients with RPF do not have characteristic imaging findings. Contrary to prior publications, absence of aortic displacement is not seen in all patients with RPF and is seen in some cancer patients. Nonetheless, when infiltrative peri-aortic retroperitoneal soft tissue that does not displace the aorta is encountered on CT or MRI, RPF can be diagnosed with a high degree of confidence, obviating the need for biopsy.
Literatur
1.
Zurück zum Zitat Swartz R (2009) Idiopathic fibrosis: a review of the pathogenesis and approaches to treatment. Am J Kid Dis 2009(54):546–553CrossRef Swartz R (2009) Idiopathic fibrosis: a review of the pathogenesis and approaches to treatment. Am J Kid Dis 2009(54):546–553CrossRef
2.
Zurück zum Zitat Kermani TA, Crowson CS, Achenbach MS, Luthra HS (2011) Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes. Mayo Clin Proc 86:297–303CrossRefPubMedPubMedCentral Kermani TA, Crowson CS, Achenbach MS, Luthra HS (2011) Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes. Mayo Clin Proc 86:297–303CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Li KP, Zhu J, Zhang J (2011) Idiopathic retroperitoneal fibrosis (RPF): clinical features of 61 cases and literature review. Clin Rheumatol 30:601–605CrossRefPubMed Li KP, Zhu J, Zhang J (2011) Idiopathic retroperitoneal fibrosis (RPF): clinical features of 61 cases and literature review. Clin Rheumatol 30:601–605CrossRefPubMed
4.
Zurück zum Zitat Scheel PJ, Feeley N (2013) Retroperitoneal fibrosis. Rheum Dis Clin N Am 39:365–381CrossRef Scheel PJ, Feeley N (2013) Retroperitoneal fibrosis. Rheum Dis Clin N Am 39:365–381CrossRef
5.
Zurück zum Zitat Liu H, Zhang G, Niu Y, Jiang N, Xiao W (2014) Retroperitoneal fibrosis: a clinical and outcome analysis of 58 cases and review of the literature. Rheumatol Int 34:1665–1670CrossRefPubMed Liu H, Zhang G, Niu Y, Jiang N, Xiao W (2014) Retroperitoneal fibrosis: a clinical and outcome analysis of 58 cases and review of the literature. Rheumatol Int 34:1665–1670CrossRefPubMed
6.
7.
Zurück zum Zitat Goldini M, Bonini S, Urban M, et al. (2014) Asbestos and smoking as risk factors for idiopathic retroperitoneal fibrosis. Ann Intern Med 161:181–188CrossRef Goldini M, Bonini S, Urban M, et al. (2014) Asbestos and smoking as risk factors for idiopathic retroperitoneal fibrosis. Ann Intern Med 161:181–188CrossRef
8.
Zurück zum Zitat Swartz RD (2015) Retroperitoneal fibrosis and asbestosis—a plausible association? Am J Kidney Dis 65:378–380CrossRefPubMed Swartz RD (2015) Retroperitoneal fibrosis and asbestosis—a plausible association? Am J Kidney Dis 65:378–380CrossRefPubMed
10.
11.
Zurück zum Zitat Pelkman L, Aarndouse A, Hendriksz T, van Bommel E (2012) Value of acute-phase reactants in monitoring disease activity and response to treatment in idiopathic retroperitoneal fibrosis. Neph Dial Transpl 27:2815–2819 Pelkman L, Aarndouse A, Hendriksz T, van Bommel E (2012) Value of acute-phase reactants in monitoring disease activity and response to treatment in idiopathic retroperitoneal fibrosis. Neph Dial Transpl 27:2815–2819
12.
Zurück zum Zitat Gilkeson GS, Allen NB (1996) Retroperitoneal fibrosis: a true connective tissue disease. Rheum Dis Clin N Am 22:23–38CrossRef Gilkeson GS, Allen NB (1996) Retroperitoneal fibrosis: a true connective tissue disease. Rheum Dis Clin N Am 22:23–38CrossRef
13.
Zurück zum Zitat Degesys G, Dunnick NR, Silverman PM, et al. (1986) Retroperitoneal fibrosis: use of CT in distinguishing among possible causes. AJR 146:57–60CrossRefPubMed Degesys G, Dunnick NR, Silverman PM, et al. (1986) Retroperitoneal fibrosis: use of CT in distinguishing among possible causes. AJR 146:57–60CrossRefPubMed
15.
Zurück zum Zitat Oliveira Caiafa R, Sierra Vinuesa A, Salvador Izquierdo R, et al. (2013) Retroperitoneal fibrosis: role of imaging in diagnosis and follow up. Radiographics 33:535–552CrossRef Oliveira Caiafa R, Sierra Vinuesa A, Salvador Izquierdo R, et al. (2013) Retroperitoneal fibrosis: role of imaging in diagnosis and follow up. Radiographics 33:535–552CrossRef
16.
Zurück zum Zitat Baker LR, Mallinson WJ, Gregory MC, et al. (1987) Idiopathic retroperitoneal fibrosis: a retrospective analysis of 60 cases. Br J Urol 60:497–503CrossRefPubMed Baker LR, Mallinson WJ, Gregory MC, et al. (1987) Idiopathic retroperitoneal fibrosis: a retrospective analysis of 60 cases. Br J Urol 60:497–503CrossRefPubMed
17.
Zurück zum Zitat Rosenkrantz AB, Spieler B, Seuss CR, Stifelman MD, Kim S (2012) Utility of MRI features for differentiation of retroperitoneal fibrosis and lymphoma. AJR 199:118–126CrossRefPubMed Rosenkrantz AB, Spieler B, Seuss CR, Stifelman MD, Kim S (2012) Utility of MRI features for differentiation of retroperitoneal fibrosis and lymphoma. AJR 199:118–126CrossRefPubMed
18.
Zurück zum Zitat Bakir B, Yilmaz F, Turkay R, et al. (2014) Role of diffusion-weighted MR imaging in the differentiation of benign retroperitoneal fibrosis from malignant neoplasm: preliminary study. Radiology 272:438–445CrossRefPubMed Bakir B, Yilmaz F, Turkay R, et al. (2014) Role of diffusion-weighted MR imaging in the differentiation of benign retroperitoneal fibrosis from malignant neoplasm: preliminary study. Radiology 272:438–445CrossRefPubMed
19.
Zurück zum Zitat Stone J (2012) IgG4-related disease: nomenclature, clinical features, and treatment. Semin Diagn Pathol 29:177–190CrossRefPubMed Stone J (2012) IgG4-related disease: nomenclature, clinical features, and treatment. Semin Diagn Pathol 29:177–190CrossRefPubMed
20.
Zurück zum Zitat Mahajan V, Mattoo H, Deshpande V, Pillai S, Sonte J (2014) IgG4-related disease. Ann Rev Pathol Mech Dis 9:315–347CrossRef Mahajan V, Mattoo H, Deshpande V, Pillai S, Sonte J (2014) IgG4-related disease. Ann Rev Pathol Mech Dis 9:315–347CrossRef
21.
Zurück zum Zitat Khosroshahi A, Wallace ZS, Crowe JL, et al. (2015) International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 67:1688–1699CrossRefPubMed Khosroshahi A, Wallace ZS, Crowe JL, et al. (2015) International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 67:1688–1699CrossRefPubMed
22.
Zurück zum Zitat Chiba K, Kamisawa T, Tabata T, et al. (2013) Clinical features of 10 patients with IgG4-related retroperitoneal fibrosis. Int Med 52:1545–1551CrossRef Chiba K, Kamisawa T, Tabata T, et al. (2013) Clinical features of 10 patients with IgG4-related retroperitoneal fibrosis. Int Med 52:1545–1551CrossRef
Metadaten
Titel
Imaging appearance of fibrosing diseases of the retroperitoneum: can a definitive diagnosis be made?
verfasst von
Richard H. Cohan
Kimberley L. Shampain
Isaac R. Francis
Matthew S. Davenport
J. Stuart Wolf
Wendy Marder
Richard D. Swartz
Publikationsdatum
28.08.2017
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 5/2018
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1282-5

Weitere Artikel der Ausgabe 5/2018

Abdominal Radiology 5/2018 Zur Ausgabe

Classics in Abdominal Imaging

Double diaphragmatic contour

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.